Epicrispr Biotechnologies vs Summation Bio, Inc.
Epicrispr Biotechnologies vs Summation Bio, Inc., compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Summation Bio, Inc. on 41/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 41/100
- agent readiness: 39/100 against 22/100
- funding raised: $90.0M against $10.0M
Summation Bio, Inc.
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Epicrispr Biotechnologies | Summation Bio, Inc. |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Biotechnology company |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotech, Drug Discovery, Genomics, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2021 |
| Headquarters | South San Francisco, United States | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Summation Bio, Inc. |
|---|---|---|
| Employees | 51 | Not published |
| Total funding | $90.0M | $10.0M |
| Latest round | Series C | Seed |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Summation Bio, Inc. |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 41/100 |
| Traction | 57/100 | 35/100 |
| Team | 40/100 | 60/100 |
| Community | Not published | 15/100 |
| Search visibility | 20/100 | 15/100 |
| Quality | 78/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 40/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Summation Bio, Inc. |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs Summation Bio, Inc.: common questions
Which is better, Epicrispr Biotechnologies or Summation Bio, Inc.?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Summation Bio, Inc. compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 41/100), agent readiness (39/100 against 22/100), funding raised ($90.0M against $10.0M).
Read the full Epicrispr Biotechnologies review and pricing or the Summation Bio, Inc. review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.